Immunomodulation of the anti-islet CD8 T cell response by B7-2

Journal of Clinical Immunology

Volumn 27, Issue 2, 2007, Pages 221-226

  Yadav, Deepak ^a   Sarvetnick, Nora ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

B7 2; CD8 T cell; Costimulation; Type 1 diabetes

Indexed keywords

CD86 ANTIGEN;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNITY; CD8+ T LYMPHOCYTE; CELL SURVIVAL; CONTROLLED STUDY; EFFECTOR CELL; FEMALE; IMMUNE RESPONSE; IMMUNOMODULATION; IN VITRO STUDY; LYMPH NODE; LYMPHOCYTE ACTIVATION; LYMPHOCYTE FUNCTION; MOUSE; NONHUMAN; PANCREAS ISLET; PRIORITY JOURNAL;

ADOPTIVE TRANSFER; ANIMALS; ANTIGENS, CD86; CD8-POSITIVE T-LYMPHOCYTES; DIABETES MELLITUS, TYPE 1; FEMALE; FLOW CYTOMETRY; ISLETS OF LANGERHANS; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED NOD; MICE, TRANSGENIC;

EID: 33847372904     PISSN: 02719142     EISSN: 15732592     Source Type: Journal    
DOI: 10.1007/s10875-006-9067-6     Document Type: Article

References (23)

1. Schweitzer AN, Borriello F, Wong RC, Abbas AK, Sharpe AH: Role of costimulators in T cell differentiation: Studies using antigen-presenting cells lacking expression of CD80 or CD86. J Immunol 158:2713-2722, 1997
2. Lanier LL, O'Fallon S, Somoza C, Phillips JH, Linsley PS, Okumura K, Ito D, Azuma M: CD80 (B7) and CD86 (B70) provide similar costimulatory signals for T cell proliferation, cytokine production, and generation of CTL. J Immunol 154:97-105, 1995
3. Slavik JM, Hutchcroft JE, Bierer BE: CD80 and CD86 are not equivalent in their ability to induce the tyrosine phosphorylation of CD28. J Biol Chem 274:3116-3124, 1999
4. Guerder S, Eynon EE, Flavell RA: Autoimmunity without diabetes in transgenic mice expressing beta cell-specific CD86, but not CD80: Parameters that trigger progression to diabetes. J Immunol 161:2128-2140, 1998
5. Salomon B, Bluestone JA: Complexities of CD28/B7: CTLA-4 costimulatory pathways in autoimmunity and transplantation. Annu Rev Immunol 19:225-252, 2001
6. Salomon B, Rhee L, Bour-Jordan H, Hsin H, Montag A, Soliven B, Arcella J, Girvin AM, Padilla J, Miller SD, Bluestone JA: Development of spontaneous autoimmune peripheral polyneuropathy in B7-2-deficient NOD mice. J Exp Med 194:677-684, 2001
7. Yadav D, Judkowski V, Flodstrom-Tullberg M, Sterling L, Redmond WL, Sherman L, Sarvetnick N: B7-2 (CD86) controls the priming of autoreactive CD4 T cell response against pancreatic islets. J Immunol 173:3631-3639, 2004
8. Lang TJ, Nguyen P, Peach R, Gause WC, Via CS: In vivo CD86 blockade inhibits CD4+ T cell activation, whereas CD80 blockade potentiates CD8+ T cell activation and CTL effector function. J Immunol 168:3786-3792, 2002
9. Fields PE, Finch RJ, Gray GS, Zollner R, Thomas JL, Sturmhoefel K, Lee K, Wolf S, Gajewski TF, Fitch FW: B7.1 is a quantitatively stronger costimulus than B7.2 in the activation of naive CD8+ TCR-transgenic T cells. J Immunol 161:5268-5275, 1998
10. Vu MD, Amanullah F, Li Y, Demirci G, Sayegh MH, Li XC: Different costimulatory and growth factor requirements for CD4+ and CD8+ T cell-mediated rejection. J Immunol 173:214-221, 2004
11. Agadjanyan MG, Kim JJ, Trivedi N, Wilson DM, Monzavi-Karbassi B, Morrison LD, Nottingham LK, Dentchev T, Tsai A, Dang K, Chalian AA, Maldonado MA, Williams WV, Weiner DB: CD86 (B7-2) can function to drive MHC-restricted antigen-specific CTL responses in vivo. J Immunol 162:3417-3427, 1999
12. Buggins AG, Lea N, Gaken J, Darling D, Farzaneh F, Mufti GJ, Hirst WJ: Effect of costimulation and the microenvironment on antigen presentation by leukemic cells. Blood 94:3479-3490, 1999
13. Deeths MJ, Mescher MF: B7-1-dependent co-stimulation results in qualitatively and quantitatively different responses by CD4+ and CD8+ T cells. Eur J Immunol 27:598-608, 1997
14. Lieberman SM, Evans AM, Han B, Takaki T, Vinnitskaya Y, Caldwell JA, Serreze DV, Shabanowitz J, Hunt DF, Nathenson SG, Santamaria P, DiLorenzo TP: Identification of the beta cell antigen targeted by a prevalent population of pathogenic CD8+ T cells in autoimmune diabetes. Proc Natl Acad Sci USA 100:8384-8388, 2003
15. Zajac AJ, Blattman JN, Murali-Krishna K, Sourdive DJ, Suresh M, Altman JD, Ahmed R: Viral immune evasion due to persistence of activated T cells without effector function. J Exp Med 188:2205-2213, 1998
16. Verdaguer J, Schmidt D, Amrani A, Anderson B, Averill N, Santamaria P: Spontaneous autoimmune diabetes in monoclonal T cell nonobese diabetic mice. J Exp Med 186:1663-1676, 1997
17. Yoon JW, Jun HS, Santamaria P: Cellular and molecular mechanisms for the initiation and progression of beta cell destruction resulting from the collaboration between macrophages and T cells. Autoimmunity 27:109-122, 1998
18. Grayson JM, Zajac AJ, Altman JD, Ahmed R: Cutting edge: Increased expression of Bcl-2 in antigen-specific memory CD8+ T cells. J Immunol 164:3950-3954, 2000
19. Murali-Krishna K, Ahmed R: Cutting edge: Naive T cells masquerading as memory cells. J Immunol 165:1733-1737, 2000
20. Khanolkar A, Fuller MJ, Zajac AJ: CD4 T cell-dependent CD8 T cell maturation. J Immunol 172:2834-2844, 2004
21. Kaech SM, Ahmed R: Immunology. CD8 T cells remember with a little help. Science 300:263-265, 2003
22. Bour-Jordan H, Salomon BL, Thompson HL, Szot GL, Bernhard MR, Bluestone JA: Costimulation controls diabetes by altering the balance of pathogenic and regulatory T cells. J Clin Invest 114:979-987, 2004
23. Viglietta V, Kent SC, Orban T, Hafler DA: GAD65-reactive T cells are activated in patients with autoimmune type 1a diabetes. J Clin Invest 109:895-903, 2002